scispace - formally typeset
M

Masanori Miwa

Researcher at Takeda Pharmaceutical Company

Publications -  19
Citations -  1730

Masanori Miwa is an academic researcher from Takeda Pharmaceutical Company. The author has contributed to research in topics: Peptide & Recombinant DNA. The author has an hindex of 9, co-authored 19 publications receiving 1471 citations.

Papers
More filters
Journal ArticleDOI

A G Protein-coupled Receptor Responsive to Bile Acids

TL;DR: It is found that a novel G protein-coupled receptor, TGR5, is responsive to bile acids as a cell-surface receptor, and was abundantly expressed in monocytes/macrophages in human and rabbit.
Patent

Novel g protein-coupled receptor protein and dna thereof

TL;DR: A human-origin protein or its salt can be used in determining a ligand to this protein; preventives and/or remedies for diseases in association with the dysfunction of the above protein; screening compounds (agonists, antagonists, etc.) capable of altering binding properties of the ligand as discussed by the authors.
Journal ArticleDOI

K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology

TL;DR: In this paper, the authors reported novel and selective inhibitory peptides to K-Ras(G12D) and obtained KRpep-2 (Ac-RRCPLYISYDPVCRR-NH2) as a consensus sequence.
Journal ArticleDOI

Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d

TL;DR: The crystal structure of the human K-Ras(G12D) mutant was determined and revealed that the peptide binds near Switch II and allosterically blocks protein-protein interactions with the guanine nucleotide exchange factor, providing valuable information that will facilitate the design of direct Ras inhibitors.
Journal ArticleDOI

Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2

TL;DR: The discovery of the potent and selective Brr2 inhibitor 9 with helicase inhibitory activity demonstrates an effective strategy to explore selective inhibitors for helicases, and could be a promising starting point for exploring molecular probes to elucidate biological functions and the therapeutic relevance of Brr1.